Subsequently, Mondul et al. found in NAFLD patients that carriers of the PNPLA3 I148M mutation have lower circulating levels of retinyl palmitate and RBP4 but not β-carotene concentrations [37]. The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.